Please use this identifier to cite or link to this item:
https://dipositint.ub.edu/dspace/handle/2445/32186
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Junyent Herena, Fèlix | - |
dc.contributor.author | Verdaguer Cardona, Ester | - |
dc.contributor.author | Folch, Jaume | - |
dc.contributor.author | Beas Zárate, Carlos | - |
dc.contributor.author | Pallàs i Llibería, Mercè, 1964- | - |
dc.contributor.author | Auladell i Costa, M. Carme | - |
dc.contributor.author | Camins Espuny, Antoni | - |
dc.date.accessioned | 2012-10-04T10:37:46Z | - |
dc.date.available | 2012-10-04T10:37:46Z | - |
dc.date.issued | 2012 | - |
dc.identifier.uri | https://hdl.handle.net/2445/32186 | - |
dc.description | Podeu consultar el llibre complet a: http://hdl.handle.net/2445/32393 | - |
dc.description.abstract | The c-Jun N-terminal kinases (JNK) are members of the MAPK family and can be activated by different stimuli such as cellular stress, heat shock and ultra-violet irradiation. JNKs have different physiological functions and they have been linked to apoptosis in different cell types. Therefore, the JNK signalling pathway is an important target to prevent cell death. In the present chapter, the role of JNKs in neurodegenerative diseases will be discussed, as well as the pharmacological compounds that inhibit this signalling pathway as therapeutic intervention to prevent neuronal death. | eng |
dc.format.extent | 14 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | eng |
dc.publisher | Transworld Research Network | - |
dc.relation.isformatof | Reproducció del capítol 2 del llibre publicat a: http://www.trnres.com/ebookcontents.php?id=131 | - |
dc.relation.ispartof | Recent Advances in Pharmaceutical Sciences II, 2012, Editor: Diego Muñoz-Torrero, Diego Haro and Joan Vallès, Chapter 2, p. 15-28. | - |
dc.relation.uri | http://hdl.handle.net/2445/32393 | - |
dc.rights | (c) Transworld Research Network, 2012 | - |
dc.source | Llibres / Capítols de llibre (Farmacologia, Toxicologia i Química Terapèutica) | - |
dc.subject.classification | Farmacologia | cat |
dc.subject.classification | Malalties neurodegeneratives | cat |
dc.subject.other | Pharmacology | eng |
dc.subject.other | Neurodegenerative Diseases | eng |
dc.title | Role of JNK in neurodegenerative diseases | eng |
dc.type | info:eu-repo/semantics/bookPart | eng |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 268408 | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | eng |
Appears in Collections: | Llibres / Capítols de llibre (Biologia Cel·lular, Fisiologia i Immunologia) Llibres / Capítols de llibre (Farmacologia, Toxicologia i Química Terapèutica) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
RAPS_II_Ch2.pdf | 217.06 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.